MAOB and Parkinson disease: Therefore, a major treatment strategy for PD focuses on DA supplementation, through the use of DA precursors such as levodopa (L-DOPA) [4], DA receptor agonists, and monoamine oxidase B (MAO-B) inhibitors [1, 5].